Home » Stocks » CRXM

Gene Biotherapeutics Inc. (CRXM)

Stock Price: $0.0540 USD 0.0040 (8.00%)
Updated May 7, 2021 3:56 PM EDT - Market closed
Market Cap 2.68M
Revenue (ttm) n/a
Net Income (ttm) 866,675
Shares Out 14.49M
EPS (ttm) 0.06
PE Ratio 0.90
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 7
Last Price $0.0540
Previous Close $0.0500
Change ($) 0.0040
Change (%) 8.00%
Day's Open 0.0540
Day's Range 0.0531 - 0.0570
Day's Volume 810,888
52-Week Range 0.0204 - 0.1500

News

There are no news available yet.

About CRXM

Gene Biotherapeutics, Inc. manages a portfolio of medical technologies in the United States. It focuses on acquiring and developing gene-based therapeutics. The company, through its subsidiary, Angionetics, Inc., focuses on the clinical advancement and commercialization of Generx, an interventional cardiology, angiogenic gene therapy Phase 3 product candidate designed for the potential treatment of patients with refractory angina due to advanced coronary artery disease. It also holds royalties on the commercialization of Excellagen technology p... [Read more...]

Industry
Biotechnology
Founded
2003
CEO
Christopher Reinhard
Employees
4
Stock Exchange
OTCMKTS
Ticker Symbol
CRXM
Full Company Profile

Financial Performance

Financial Statements